Savara Inc. (the “Company”) (Nasdaq: SVRA ), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, today announced that it has received the Day 74 L ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results